Advertisement
U.S. Markets open in 3 hrs 54 mins

Profound Medical Corp. (PROF)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
7.84-0.17 (-2.12%)
At close: 04:00PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close8.01
Open7.93
Bid5.76 x 200
Ask10.02 x 200
Day's Range7.77 - 7.96
52 Week Range7.11 - 11.42
Volume12,051
Avg. Volume50,368
Market Cap193.349M
Beta (5Y Monthly)0.83
PE Ratio (TTM)N/A
EPS (TTM)-1.34
Earnings DateNov 07, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est15.17
  • GlobeNewswire

    Profound Medical to Participate in the Stifel 2024 Healthcare Conference

    TORONTO, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that management will present an update on the Company’s business at the Stifel 2024 Healthcare Conference on Tuesday, November 19, 2024 at 9:45 a.m. Eastern Time in NYC. The presentation will be broadcast live and archive

  • Simply Wall St.

    Profound Medical Third Quarter 2024 Earnings: Misses Expectations

    Profound Medical ( TSE:PRN ) Third Quarter 2024 Results Key Financial Results Net loss: US$9.36m (loss widened by 68...